Equillium Inc
NASDAQ:EQ

Watchlist Manager
Equillium Inc Logo
Equillium Inc
NASDAQ:EQ
Watchlist
Price: 0.3405 USD 2.01% Market Closed
Market Cap: 12.2m USD

Wall Street
Price Targets

EQ Price Targets Summary
Equillium Inc

Wall Street analysts forecast EQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EQ is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Lowest
Price Target
1.01 USD
197% Upside
Average
Price Target
1.02 USD
200% Upside
Highest
Price Target
1.05 USD
208% Upside
Equillium Inc Competitors:
Price Targets
ARMP
Armata Pharmaceuticals Inc
381% Upside
CVAC
CureVac NV
2% Downside
251120
Bio-FD&C Co Ltd
5% Downside
QURE
Uniqure NV
160% Upside
VCEL
Vericel Corp
48% Upside
6955
Shandong Boan Biotechnology Co Ltd
12% Downside
CRNX
Crinetics Pharmaceuticals Inc
152% Upside
688293
Shanghai OPM Biosciences Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Equillium Inc

The compound annual growth rate of Equillium Inc's revenue for the next 3 years is 9%.

N/A
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Equillium Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Equillium Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EQ's stock price target?
Price Target
1.02 USD

According to Wall Street analysts, the average 1-year price target for EQ is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

What is Equillium Inc's Revenue forecast?
Projected CAGR
9%

The compound annual growth rate of Equillium Inc's revenue for the next 3 years is 9%.

Back to Top